Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-22 9:32:3 am | Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference | GlobeNewsWire |
| 2024-01-22 4:30:0 am | Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601 | GlobeNewswire |
| 2024-01-08 6:31:7 am | Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization | Benzinga |
| 2024-01-08 5:24:0 am | Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information